Total recalls 9 since 2015
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 0 latest 7 Feb 2024
Recalls per month, last 24 months click a bar for that month Severity split
0 0%9 100%0 0%
All rifampin recalls, newest first 9 total Reported Class Recall Company Reason Where 7 Feb 2024 Drug CLASS II Rifampin Capsules USP 300mg recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Potency & Assay MD 7 Feb 2024 Drug CLASS II Rifampin Capsules USP, 150 mg doses recalled Rifampin Amerisource Health Services Potency & Assay Nationwide 7 Feb 2024 Drug CLASS II Rifampin Capsules USP 150mg recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Potency & Assay MD 25 Jan 2023 Drug CLASS II Rifampin Capsules USP, 300 mg (10 x recalled Rifampin Amerisource Health Services Potency & Assay Nationwide 18 Jan 2023 Drug CLASS II Rifampin Capsules USP, 300 mg recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Potency & Assay Nationwide 24 Aug 2022 Drug CLASS II Rifampin Capsules, USP, 150 mg HDPE recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Nitrosamine Impurity Nationwide 27 Apr 2022 Drug CLASS II Rifampin for Injection, USP, 600 mg/vial, One Vial recalled Rifampin Mylan Pharmaceuticals Potency & Assay Nationwide 16 Oct 2019 Drug CLASS II Rifampin for Injection, USP, 600 mg/vial recalled Rifampin Mylan Laboratories Limited (Sterile Products Division) Potency & Assay Nationwide 22 Jul 2015 Drug CLASS II Rifampin for Injection, USP 600mg/vial in a vial recalled Rifampin Fresenius Kabi USA Potency & Assay Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.